OR WAIT null SECS
March 11, 2025
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments, in an interview with Pharmaceutical Technology®.
March 10, 2025
The ‘full tolerance coverage method’ is introduced as a coverage estimation approach for assessing the uniformity of dosage units from large sample sizes, ensuring that no dosage unit exceeds the specification range.
March 07, 2025
Being fully versed on the ins and outs of design quality can improve the project design phase life cycle.
March 06, 2025
The alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.
In an interview with Pharmaceutical Technology®, Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
March 04, 2025
Compliance and competitiveness are key factors in aseptic processing, says Siegfried Schmitt, PhD, vice president, Technical at Parexel.
March 03, 2025
Artificial intelligence, among other technological advances, is pushing innovation boundaries.
February 28, 2025
Treatments for autoimmune diseases, multiple cancers, and skin blistering have been recommended for marketing approval.
February 27, 2025
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes in an interview with Pharmaceutical Technology®.
February 25, 2025
Sponsor companies and contract development and manufacturing companies must ensure that the suppliers they use are following sustainability guidelines to truly produce ‘green’ products.